Effects of Autogenic Drainage and Flutter Device in COPD
NCT: NCT07713043 · NOT_YET_RECRUITING
Brief Summary
COPD is a progressive lung disease that includes emphysema and chronic bronchitis and is a major cause of morbidity and mortality worldwide. Airway clearance techniques help improve mucus removal, reduce dyspnea, and enhance quality of life in COPD patients. This study aims to compare the effects of autogenic drainage and flutter device on dyspnea, pulmonary function, and functional capacity in patients with COPD. A randomized clinical trial will be conducted at Gulab Devi Teaching Hospital using convenient sampling. Participants will be divided into two groups: Group A will receive autogenic drainage, while Group B will use the flutter device. Interventions will be performed daily for 20-30 minutes over 6 weeks. Outcome measures will include dyspnea severity scale, spirometry, and 6-minute walk test. Data will be analyzed using SPSS with significance set at p \< 0.05. The study may provide evidence for effective, non-invasive, and cost-effective management strategies for COPD patients.
Frequently Asked Questions
What is Effects of Autogenic Drainage and Flutter Device in COPD?
Effects of Autogenic Drainage and Flutter Device in COPD is a clinical trial registered under NCT07713043. Current status: NOT_YET_RECRUITING.
What is the status of NCT07713043?
The current status of NCT07713043 (Effects of Autogenic Drainage and Flutter Device in COPD) is: NOT_YET_RECRUITING.
When did Effects of Autogenic Drainage and Flutter Device in COPD start?
Effects of Autogenic Drainage and Flutter Device in COPD started on 2026-06.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.